Provided by Tiger Fintech (Singapore) Pte. Ltd.

Day One Biopharmaceuticals Inc.

6.67
-0.0200-0.30%
Post-market: 6.53-0.1409-2.11%19:24 EDT
Volume:1.16M
Turnover:7.70M
Market Cap:676.09M
PE:-9.39
High:6.75
Open:6.57
Low:6.53
Close:6.69
Loading ...

New Strong Buy Stocks for February 13th

Zacks
·
13 Feb

Day One to Report Fourth Quarter and Full-Year 2024 Financial Results Tuesday, February 25, 2025

GlobeNewswire
·
11 Feb

Analysts Are Bullish on These Healthcare Stocks: Day One Biopharmaceuticals (DAWN), Health Catalyst (HCAT)

TIPRANKS
·
11 Feb

Tara Bancroft’s Buy Rating: Ojemda’s Promising Growth and Strong Financial Prospects

TIPRANKS
·
29 Jan

Why Is Andreas Halvorsen Bullish On Day One Biopharmaceuticals, Inc. (DAWN) Now?

Insider Monkey
·
23 Jan

Strategic Positioning and Growth Potential of Day One Biopharmaceuticals: A Buy Rating Driven by Ojemda’s Market Penetration

TIPRANKS
·
16 Jan

Day One Biopharm Price Target Maintained With a $33.00/Share by Needham

Dow Jones
·
14 Jan

Optimistic Outlook for Day One Biopharmaceuticals: Strong Sales Performance and Promising Pipeline Support Buy Rating

TIPRANKS
·
13 Jan

Press Release: Day One Reports Preliminary 2024 OJEMDA(TM) Net Product Revenue and Highlights 2025 Corporate Priorities

Dow Jones
·
13 Jan

Day One Biopharm Is Maintained at Buy by B of A Securities

Dow Jones
·
08 Jan

BofA Securities Adjusts Price Target on Day One Biopharmaceuticals to $25 From $28, Maintains Buy Rating

MT Newswires Live
·
07 Jan

3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2025

Zacks
·
27 Dec 2024

High Growth Tech Stocks to Watch in December 2024

Simply Wall St.
·
24 Dec 2024

Day One Biopharmaceuticals (DAWN) Posts Stellar Q3 but with Extreme Concentration Risk

TIPRANKS
·
17 Dec 2024

What’s New in DePin? VanEck Invests in DAWN, IoTeX Blockchain Association, And More

BE[IN]CRYPTO
·
17 Dec 2024

Day One price target lowered to $34 from $39 at JonesResearch

TIPRANKS
·
17 Dec 2024